Q2 2025 13F Holders as of 30 Jun 2025
-
Type / Class
-
Equity / Common Shares, no par value
-
Shares outstanding
-
34,309,263
-
Total 13F shares
-
13,599,927
-
Share change
-
+248,250
-
Total reported value
-
$112,877,891
-
Price per share
-
$8.30
-
Number of holders
-
77
-
Value change
-
+$2,365,576
-
Number of buys
-
40
-
Number of sells
-
29
Institutional Holders of FENNEC PHARMACEUTICALS INC. - Common Shares, no par value (FENC) as of Q2 2025
As of 30 Jun 2025,
FENNEC PHARMACEUTICALS INC. - Common Shares, no par value (FENC) was held by
77 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
13,599,927 shares.
The largest 10 holders included
Southpoint Capital Advisors LP, Solas Capital Management, LLC, Rosalind Advisors, Inc., BlackRock, Inc., VANGUARD GROUP INC, AIGH Capital Management LLC, STATE STREET CORP, GEODE CAPITAL MANAGEMENT, LLC, HARBERT FUND ADVISORS, INC., and MORGAN STANLEY.
This page lists
77
institutional shareholders reporting positions in this security
for the Q2 2025 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.